[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100583914":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":20,"centralContacts":21,"locations":27,"responsibleParty":40,"collaborators":20,"id":44,"slug":45,"hasResults":46,"nctId":47,"briefTitle":48,"officialTitle":49,"acronym":50,"eligibilityCriteria":51,"healthyVolunteers":46,"sex":52,"minAge":53,"maxAge":20,"enrollmentInfo":54,"targetDuration":20,"studyType":57,"phases":58,"briefSummary":60,"conditions":61,"keywords":64,"overallStatus":67,"whyStopped":20,"lastUpdateSubmitDate":68,"lastUpdatePostDateStruct":69,"startDateStruct":72,"completionDateStruct":74,"leadSponsor":76,"locationsCount":77},{"fullName":5,"class":6},"Ankara City Hospital Bilkent","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Patients who are referred from the dermatology clinic or voluntarily present to our pain management","ACTIVE_COMPARATOR","The result of the study will provide insight into how much subcutaneous lidocaine injection, applied to patients with pain due to acute HZ and PHN, reduces pain, compare the effectiveness between its application in the acute and chronic phases, and determine its contribution to preventing the development of PHN. Based on the outcome, the effectiveness of this treatment can be demonstrated.",[13],"Procedure: Lidocaine (drug)",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":20},"PROCEDURE","Lidocaine (drug)","Lidocain subcuteous infiltratyion will be done to rush area.",[9],null,[22],{"name":23,"role":24,"phone":25,"phoneExt":20,"email":26},"Ali Çoştu Çostu, MD","CONTACT","+905427669038","alicostu@gmail.com",[28],{"facility":29,"status":20,"city":30,"state":31,"zip":32,"country":33,"countryCode":20,"cosmosGeoPoint":34,"geoPoint":39,"contacts":20},"Üniversiteler Mahallesi 1604. Cadde No: 9 Çankaya\u002FANKARA","Ankara","Cankaya","06800","Turkey (Türkiye)",{"type":35,"coordinates":36},"Point",[37,38],32.85427,39.91987,{"lat":38,"lon":37},{"type":41,"investigatorFullName":42,"investigatorTitle":43,"investigatorAffiliation":5,"oldNameTitle":20,"oldOrganization":20},"PRINCIPAL_INVESTIGATOR","Ülkü Sabuncu","Medical doctor","100583914","subcutaneous-lidocaine-injection-in-acute-herpes-zoster-neuralgia-and-post-herpetic-neuralgia-100583914",false,"NCT06882525","Subcutaneous Lidocaine Injection in Acute Herpes Zoster Neuralgia and Post-herpetic Neuralgia","The Evaluation of the Effectiveness of Subcutaneous Lidocaine Injection in Acute Herpes Zoster Neuralgia and Post-herpetic Neuralgia","SCL-HZ\u002FPHN","Inclusion Criteria:\n\n* patients over the age of 18\n* with acute HZ pain (rash duration \\\u003C 30 days\n* pain due to PHN (rash duration \\> 3 months),\n\nExclusion Criteria:\n\npatients on anticoagulants or have coagulation disorders, patients with psychomotor disorders patients with uncontrolled diabetes patients with bacterial infection or infectious discharge in the affected dermatomal region patients allergic to lidocaine patients with lesions in the facial or genital regions pregnant or breastfeeding patients","ALL","18 Years",{"count":55,"type":56},76,"ESTIMATED","INTERVENTIONAL",[59],"NA","In this study, it was aimed to compare the effect of subcutaneous lidocaine injection, which is routinely applied in pain clinic,in patients who present with pain complaints due to acute herpes zoster and post-herpetic neuralgia, and investigate its contribution to preventing the development of post-herpetic neuralgia",[62,63],"Herpes Zoster","Neuralgia, Postherpetic",[63,65,66],"HERPES ZOSTER","Lidocaine","NOT_YET_RECRUITING","2025-03-17",{"date":70,"type":71},"2025-03-18","ACTUAL",{"date":73,"type":56},"2025-03-07",{"date":75,"type":56},"2025-12-06",{"name":5,"class":6},1]